Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis

Journal of Physiology

Volumn 589, Issue 9, 2011, Pages 2245-2260

  Quinlan, K A ^a   Schuster, J E ^a   Fu, R ^a   Siddique, T ^a   Heckman, C J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AFTERHYPERPOLARIZATION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CELL MATURATION; CONTROLLED STUDY; GENE MUTATION; MOUSE; MUTANT; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SODIUM CONDUCTANCE; SODIUM CURRENT; SPINAL CORD MOTONEURON; WILD TYPE;

ACTION POTENTIALS; AGING; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CALCIUM; DISEASE MODELS, ANIMAL; ELECTRIC CONDUCTIVITY; GENOTYPE; HUMANS; KINETICS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUTATION; PATCH-CLAMP TECHNIQUES; PHENOTYPE; SODIUM; SPINAL NERVES; SUPEROXIDE DISMUTASE;

EID: 79955421221     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.200659     Document Type: Article

References (80)

1. Alaburda A, Perrier JF & Hounsgaard J (2002). Mechanisms causing plateau potentials in spinal motoneurones. Adv Exp Med Biol 508, 219-226.
2. Amendola J & Durand J (2008). Morphological differences between wild-type and transgenic superoxide dismutase 1 lumbar motoneurons in postnatal mice. J Comp Neurol 511, 329-341.
3. Azbill RD, Mu X & Springer JE (2000). Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res 871, 175-180.
4. Bacman SR, Bradley WG & Moraes CT (2006). Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target? Mol Neurobiol 33, 113-131.
5. Balice-Gordon RJ, Smith DB, Goldman J, Cork LC, Shirley A, Cope TC & Pinter MJ (2000). Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease. Ann Neurol 47, 596-605.
6. Bennett DJ, Li Y & Siu M (2001). Plateau potentials in sacrocaudal motoneurons of chronic spinal rats, recorded in vitro. J Neurophysiol 86, 1955-1971.
7. Bensimon G, Lacomblez L & Meininger V (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330, 585-591.
8. Blankenship AG & Feller MB (2010). Mechanisms underlying spontaneous patterned activity in developing neural circuits. Nat Rev Neurosci 11, 18-29.
9. Boiko T, Rasband MN, Levinson SR, Caldwell JH, Mandel G, Trimmer JS & Matthews G (2001). Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 30, 91-104.
10. Boiko T, Van Wart A, Caldwell JH, Levinson SR, Trimmer JS & Matthews G (2003). Functional specialization of the axon initial segment by isoform-specific sodium channel targeting. J Neurosci 23, 2306-2313.
11. Bories C, Amendola J, Lamotte d'Incamps B & Durand J (2007). Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 25, 451-459.
12. Campbell MJ, McComas AJ & Petito F (1973). Physiological changes in ageing muscles. J Neurol Neurosurg Psychiatry 36, 174-182.
13. Carrascal L, Nieto-Gonzalez JL, Cameron WE, Torres B & Nunez-Abades PA (2005). Changes during the postnatal development in physiological and anatomical characteristics of rat motoneurons studied in vitro. Brain Res Brain Res Rev 49, 377-387.
14. Carunchio I, Curcio L, Pieri M, Pica F, Caioli S, Viscomi MT, Molinari M, Canu N, Bernardi G & Zona C (2010). Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture. Exp Neurol 226, 218-230.
15. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE & Surmeier DJ (2007). 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447, 1081-1086.
16. Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM & Gurney ME (1995). Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 6, 349-362.
17. Dal Canto MC & Gurney ME (1995). Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 676, 25-40.
18. Disterhoft JF & Oh MM (2007). Alterations in intrinsic neuronal excitability during normal aging. Aging cell 6, 327-336.
19. Elbasiouny SM, Amendola J, Durand J & Heckman CJ (2010). Evidence from computer simulations for alterations in the membrane biophysical properties and dendritic processing of synaptic inputs in mutant superoxide dismutase-1 motoneurons. J Neurosci 30, 5544-5558.
20. Gonzalez-Islas C & Wenner P (2006). Spontaneous network activity in the embryonic spinal cord regulates AMPAergic and GABAergic synaptic strength. Neuron 49, 563-575.
21. Gordon T, Ly V, Hegedus J & Tyreman N (2009). Early detection of denervated muscle fibers in hindlimb muscles after sciatic nerve transection in wild type mice and in the G93A mouse model of amyotrophic lateral sclerosis. Neurol Res 31, 28-42.
22. Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK & Hall ED (1996). Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39, 147-157.
23. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD et al (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772-1775.
24. Hebert T, Drapeau P, Pradier L & Dunn RJ (1994). Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol Pharmacol 45, 1055-1060.
25. Heckman CJ, Johnson M, Mottram C & Schuster J (2008). Persistent inward currents in spinal motoneurons and their influence on human motoneuron firing patterns. Neuroscientist 14, 264-275.
26. Hegedus J, Putman CT & Gordon T (2007). Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28, 154-164.
27. Hegedus J, Putman CT, Tyreman N & Gordon T (2008). Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 586, 3337-3351.
28. Huang CS, Song JH, Nagata K, Yeh JZ & Narahashi T (1997). Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J Pharmacol Exp Ther 282, 1280-1290.
29. Hultborn H, Brownstone RB, Toth TI & Gossard JP (2004). Key mechanisms for setting the input-output gain across the motoneuron pool. Prog Brain Res 143, 77-95.
30. Ilieva HS, Yamanaka K, Malkmus S, Kakinohana O, Yaksh T, Marsala M & Cleveland DW (2008). Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc Natl Acad Sci U S A 105, 12599-12604.
31. Jiang M, Schuster JE, Fu R, Siddique T & Heckman CJ (2009). Progressive changes in synaptic inputs to motoneurons in adult sacral spinal cord of a mouse model of amyotrophic lateral sclerosis. J Neurosci 29, 15031-15038.
32. Jiang Z, Rempel J, Li J, Sawchuk MA, Carlin KP & Brownstone RM (1999). Development of L-type calcium channels and a nifedipine-sensitive motor activity in the postnatal mouse spinal cord. Eur J Neurosci 11, 3481-3487.
33. Kong J & Xu Z (1998). Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18, 3241-3250.
34. Kullmann DM & Waxman SG (2010). Neurological channelopathies: new insights into disease mechanisms and ion channel function. J Physiol 588, 1823-1827.
35. Kuo JJ, Schonewille M, Siddique T, Schults ANA, Fu RG, Bär PR, Anelli R, Heckman CJ & Kroese ABA (2004). Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J Neurophysiol 91, 571-575.
36. + current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol 563, 843-854.
37. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Powe L, Durrleman S, Delumeau JC & Meininger V (1996). A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology 47, S242-S250.
38. 2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro. Eur J Neurosci 27, 2501-2514.
39. Landmesser LT & O'Donovan MJ (1984). Activation patterns of embryonic chick hind limb muscles recorded in ovo and in an isolated spinal cord preparation. J Physiol 347, 189-204.
40. Lape R & Nistri A (2000). Current and voltage clamp studies of the spike medium afterhyperpolarization of hypoglossal motoneurons in a rat brain stem slice preparation. J Neurophysiol 83, 2987-2995.
41. Li X, Murray K, Harvey PJ, Ballou EW & Bennett DJ (2007). Serotonin facilitates a persistent calcium current in motoneurons of rats with and without chronic spinal cord injury. J Neurophysiol 97, 1236-1246.
42. Li Y & Bennett DJ (2003). Persistent sodium and calcium currents cause plateau potentials in motoneurons of chronic spinal rats. J Neurophysiol 90, 857-869.
43. Manuel M, Iglesias C, Donnet M, Leroy F, Heckman CJ & Zytnicki D (2009). Fast kinetics, high-frequency oscillations, and subprimary firing range in adult mouse spinal motoneurons. J Neurosci 29, 11246-11256.
44. Marder E & Goaillard JM (2006). Variability, compensation and homeostasis in neuron and network function. Nat Rev Neurosci 7, 563-574.
45. Marder E & Rehm KJ (2005). Development of central pattern generating circuits. Curr Opin Neurobiol 15, 86-93.
46. Meehan CF, Moldovan M, Marklund SL, Graffmo KS, Nielsen JB & Hultborn H (2010a). Intrinsic properties of lumbar motor neurones in the adult G127insTGGG superoxide dismutase-1 mutant mouse in vivo: evidence for increased persistent inward currents. Acta Physiol (Oxf) 200, 361-376.
47. Meehan CF, Sukiasyan N, Zhang M, Nielsen JB & Hultborn H (2010b). Intrinsic properties of mouse lumbar motoneurons revealed by intracellular recording in vivo. J Neurophysiol 103, 2599-2610.
48. Mogyoros I, Kiernan MC, Burke D & Bostock H (1998). Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 121, 851-859.
49. Mohajeri MH, Figlewicz DA & Bohn MC (1998). Selective loss of α motoneurons innervating the medial gastrocnemius muscle in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 150, 329-336.
50. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME & Dal Canto MC (1996). The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci U S A 93, 5472-5477.
51. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H & Przedborski S (2007). Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10, 615-622.
52. Pambo-Pambo A, Durand J & Gueritaud JP (2009). Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice. J Neurophysiol 102, 3627-3642.
53. 2 receptors promote plateau potentials in turtle spinal motoneurons by facilitating an L-type calcium current. J Neurophysiol 89, 954-959.
54. Pieri M, Albo F, Gaetti C, Spalloni A, Bengtson CP, Longone P, Cavalcanti S & Zona C (2003a). Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett 351, 153-156.
55. Pieri M, Carunchio I, Curcio L, Mercuri NB & Zona C (2009). Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol 215, 368-379.
56. 93→Ala) mutation. Neuroscience 122, 47-58.
57. Powers RK & Binder MD (2001). Input-output functions of mammalian motoneurons. Rev Physiol Biochem Pharmacol 143, 137-263.
58. Pun S, Santos AF, Saxena S, Xu L & Caroni P (2006). Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9, 408-419.
59. Rao SD & Weiss JH (2004). Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends Neurosci 27, 17-23.
60. Rich MM, Waldeck RF, Cork LC, Balice-Gordon RJ, Fyffe RE, Wang X, Cope TC & Pinter MJ (2002). Reduced endplate currents underlie motor unit dysfunction in canine motor neuron disease. J Neurophysiol 88, 3293-3304.
61. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A et aly (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
62. Rothstein JD (1996). Excitotoxicity hypothesis. Neurology 47, S19-S25; discussion S26.
63. Rothstein JD (2009). Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65(Suppl 1), S3-S9.
64. Rush AM, Dib-Hajj SD & Waxman SG (2005). Electrophysiological properties of two axonal sodium channels, Nav1.2 and Nav1.6, expressed in mouse spinal sensory neurones. J Physiol 564, 803-815.
65. Saxena S, Cabuy E & Caroni P (2009). A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 12, 627-636.
66. Schwindt PC & Crill WE (1980). Properties of a persistent inward current in normal and TEA-injected motoneurons. J Neurophysiol 43, 1700-1724.
67. Tandan R & Bradley WG (1985). Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 18, 271-280.
68. Theiss RD & Heckman CJ (2005). Systematic variation in effects of serotonin and norepinephrine on repetitive firing properties of ventral horn neurons. Neuroscience 134, 803-815.
69. Theiss RD, Kuo JJ & Heckman CJ (2007). Persistent inward currents in rat ventral horn neurones. J Physiol 580, 507-522.
70. Tomlinson BE & Irving D (1977). The numbers of limb motor neurons in the human lumbosacral cord throughout life. J Neurol Sci 34, 213-219.
71. Urbani A & Belluzzi O (2000). Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 12, 3567-3574.
72. Van Damme P, Bogaert E, Dewil M, Hersmus N, Kiraly D, Scheveneels W, Bockx I, Braeken D, Verpoorten N, Verhoeven K, Timmerman V, Herijgers P, Callewaert G, Carmeliet P, Van Den Bosch L & Robberecht W (2007). Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci U S A 104, 14825-14830.
73. Van Den Bosch L, Van Damme P, Bogaert E & Robberecht W (2006). The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762, 1068-1082.
74. van Zundert B, Peuscher MH, Hynynen M, Chen A, Neve RL, Brown RH Jr, Constantine-Paton M & Bellingham MC (2008). Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 28, 10864-10874.
75. 2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends Neurosci 28, 494-500.
76. Vucic S & Kiernan MC (2010). Upregulation of persistent sodium conductances in familial ALS. J Neurol Neurosurg Psychiatry 81, 222-227.
77. Vucic S, Nicholson GA & Kiernan MC (2008). Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 131, 1540-1550.
78. Yang Y, Gozen O, Vidensky S, Robinson MB & Rothstein JD (2010). Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1. Glia 58, 277-286.
79. Yang Y, Gozen O, Watkins A, Lorenzini I, Lepore A, Gao Y, Vidensky S, Brennan J, Poulsen D, Won Park J, Li Jeon N, Robinson MB & Rothstein JD (2009). Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1. Neuron 61, 880-894.
80. Zona C, Ferri A, Gabbianelli R, Mercuri NB, Bernardi G, Rotilio G & Carri MT (1998). Voltage-activated sodium currents in a cell line expressing a Cu, Zn superoxide dismutase typical of familial ALS. Neuroreport 9, 3515-3518.